Adopting CDISC Standards: Our Journey With CDISC
In this case study, we explore our 23-year partnership with CDISC and we look at…
CertaraOctober 8, 2024
To Generate or Not? Where GPTs Are Most Valuable Across Your CSR
Learn where GPTs are most valuable across your CSR.
CertaraOctober 7, 2024
AIFA makeover: Italy’s leap into 2024
Explore AIFA’s regulatory transformation.
CertaraOctober 4, 2024
Predict Success Faster in Drug Discovery – Designing a More Effective Model for Drug Discovery Research
The average discovery phase of drug development lasts four and half years with just six…
CertaraOctober 2, 2024
Certara Completes Acquisition of Chemaxon
The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty…
CertaraOctober 2, 2024
Certara: Bridging Global Expertise with China’s Pharmaceutical Innovation
In a recent BioValley feature, Amin Rostami, CSO & SVP of R&D at Certara, shares…
CertaraOctober 2, 2024
Certara Drug Development & Regulatory Experts Achieve 100th Rare Disease Submission
Dedicated team of global regulatory experts drives the approval of rare disease treatments RADNOR, Pa.…
CertaraOctober 1, 2024
A Quick Guide to SDTM Domains
Our guide is a quick and thorough overview of SDTM domains, to help you implement…
CertaraSeptember 30, 2024
A Quick Guide to SDTM Dataset Creation
Our free quick guide can help you better understand SDTM datasets and get started quick…
CertaraSeptember 30, 2024
